CLDN1 knock out keratinocytes as a model to investigate multiple skin disorders
Experimental Dermatology · 2024-05 · 33 (5)
DOI: 10.1111/exd.15084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, online erschienen am 06.05.2024. Verfasst von Kimberly A Arnold und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Rochester Medical Center, Rochester, New York, USA. Hauptthemen laut MEDLINE: Keratinocytes, Claudin-1, Filaggrin Proteins, Cell Differentiation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
The transmembrane protein claudin‐1 is critical for formation of the epidermal barrier structure called tight junctions (TJ) and has been shown to be important in multiple disease states. These include neonatal ichthyosis and sclerosing cholangitis syndrome, atopic dermatitis and various viral infections. To develop a model to investigate the role of claudin‐1 in different disease settings, we used CRISPR/Cas9 to generate human immortalized keratinocyte (KC) lines lacking claudin‐1 (CLDN1 KO). We then determined whether loss of claudin‐1 expression affects epidermal barrier formation/function and KC differentiation/stratification. The absence of claudin‐1 resulted in significantly reduced barrier function in both monolayer and organotypic cultures. CLDN1 KO cells demonstrated decreases in gene transcripts encoding the barrier protein filaggrin and the differentiation marker cytokeratin‐10. Marked morphological differences were also observed in CLDN1 KO organotypic cultures including diminished stratification and reduced formation of the stratum granulosum . We also detected increased proliferative KC in the basale layer of CLDN1 KO organotypic cultures. These results further support the role of claudin‐1 in epidermal barrier and suggest an additional role of this protein in appropriate stratification of the epidermis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Rochester Medical Center, Rochester, New York, USA.
- Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
- Department of Dermatology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences (RIMLS), Nijmegen, The Netherlands.
- Department of Dermatology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
ORCID-Profile: Kimberly A Arnold, Mary C Moran, Huishan Shi, Ivonne M J J van Vlijmen-Willems, Diana Rodijk-Olthuis, Jos P H Smits, Matthew G Brewer
Zitieren
APA
Arnold, K. A., Moran, M. C., Shi, H., van Vlijmen-Willems, I. M. J. J., Rodijk-Olthuis, D., Smits, J. P. H., & Brewer, M. G. (2024). CLDN1 knock out keratinocytes as a model to investigate multiple skin disorders. Experimental Dermatology, 33(5). https://doi.org/10.1111/exd.15084
Vancouver
Arnold KA, Moran MC, Shi H, van Vlijmen-Willems IMJJ, Rodijk-Olthuis D, Smits JPH, et al. CLDN1 knock out keratinocytes as a model to investigate multiple skin disorders. Experimental Dermatology. 2024;33(5). doi:10.1111/exd.15084
BibTeX
@article{Arnold2024,
author = {Arnold, Kimberly A and Moran, Mary C and Shi, Huishan and van Vlijmen-Willems, Ivonne M J J and Rodijk-Olthuis, Diana and Smits, Jos P H and Brewer, Matthew G},
title = {CLDN1 knock out keratinocytes as a model to investigate multiple skin disorders},
journal = {Experimental Dermatology},
year = {2024},
volume = {33},
number = {5},
doi = {10.1111/exd.15084}
}
EUVIMED